LexAurum Advisors LLC Purchases Shares of 1,529 The Allstate Co. (NYSE:ALL)

LexAurum Advisors LLC purchased a new stake in shares of The Allstate Co. (NYSE:ALL - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 1,529 shares of the insurance provider's stock, valued at approximately $317,000.

Several other large investors also recently bought and sold shares of the business. Vanguard Group Inc. increased its position in shares of Allstate by 1.2% during the 4th quarter. Vanguard Group Inc. now owns 32,635,424 shares of the insurance provider's stock valued at $6,291,783,000 after purchasing an additional 389,426 shares during the last quarter. Price T Rowe Associates Inc. MD increased its position in Allstate by 2.4% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 9,334,926 shares of the insurance provider's stock valued at $1,799,681,000 after purchasing an additional 218,771 shares during the period. Bank of America Corp DE raised its holdings in shares of Allstate by 157.9% in the 4th quarter. Bank of America Corp DE now owns 6,591,138 shares of the insurance provider's stock valued at $1,270,705,000 after purchasing an additional 4,035,629 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of Allstate by 3.1% in the 4th quarter. Geode Capital Management LLC now owns 6,419,728 shares of the insurance provider's stock worth $1,236,060,000 after purchasing an additional 191,147 shares during the period. Finally, GQG Partners LLC raised its stake in Allstate by 64.1% in the fourth quarter. GQG Partners LLC now owns 4,316,516 shares of the insurance provider's stock worth $832,181,000 after buying an additional 1,685,694 shares in the last quarter. 76.47% of the stock is currently owned by institutional investors.

Allstate Price Performance

NYSE ALL traded down $4.53 on Tuesday, reaching $196.24. 1,301,624 shares of the stock traded hands, compared to its average volume of 1,613,754. The firm's fifty day simple moving average is $199.49 and its 200 day simple moving average is $197.10. The company has a quick ratio of 0.40, a current ratio of 0.36 and a debt-to-equity ratio of 0.42. The company has a market cap of $51.97 billion, a price-to-earnings ratio of 11.55, a P/E/G ratio of 1.01 and a beta of 0.35. The Allstate Co. has a 12 month low of $156.66 and a 12 month high of $213.18.

Allstate (NYSE:ALL - Get Free Report) last announced its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $3.53 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.98 by ($0.45). The company had revenue of $14.30 billion during the quarter, compared to analyst estimates of $16.41 billion. Allstate had a return on equity of 28.20% and a net margin of 7.28%. The company's revenue was up 7.8% on a year-over-year basis. During the same quarter in the previous year, the business posted $5.13 EPS. As a group, research analysts predict that The Allstate Co. will post 18.74 EPS for the current fiscal year.

Allstate announced that its Board of Directors has authorized a share buyback program on Wednesday, February 26th that permits the company to buyback $1.50 billion in shares. This buyback authorization permits the insurance provider to reacquire up to 3% of its shares through open market purchases. Shares buyback programs are generally an indication that the company's management believes its stock is undervalued.

Allstate Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, July 1st. Shareholders of record on Monday, June 9th will be given a dividend of $1.00 per share. This represents a $4.00 dividend on an annualized basis and a yield of 2.04%. The ex-dividend date of this dividend is Monday, June 9th. Allstate's dividend payout ratio (DPR) is currently 27.32%.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on ALL shares. Barclays decreased their price objective on Allstate from $183.00 to $172.00 and set an "underweight" rating for the company in a research note on Friday, April 11th. Raymond James reissued a "strong-buy" rating and issued a $250.00 price objective (up previously from $240.00) on shares of Allstate in a report on Monday, May 5th. JPMorgan Chase & Co. increased their price target on Allstate from $217.00 to $222.00 and gave the company an "overweight" rating in a report on Tuesday, April 8th. Morgan Stanley upped their price target on Allstate from $225.00 to $235.00 and gave the stock an "overweight" rating in a research note on Tuesday, May 6th. Finally, Argus upgraded shares of Allstate from a "hold" rating to a "buy" rating in a research note on Monday, March 3rd. One research analyst has rated the stock with a sell rating, one has issued a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $225.20.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.